Physician profile
Erin E Miller
NPI 1811263890
$61,993.26
in general payments reported to CMS, 2019-2025
8 companies · $3,769 in 2025
The $3,769 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $66.09 · 2021: $16K · 2022: $5,194 · 2023: $23K · 2024: $13K · 2025: $3,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $9,209 · Food and Beverage: $1,159 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,000.00 |
| Travel and Lodging | $9,208.67 |
| Food and Beverage | $1,159.26 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $61,707.45 | 2020-2025 | Gelpoint V-Path |
| Abbvie INC. | $144.63 | 2019 | |
| Pfizer INC. | $33.56 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $29.45 | 2019-2024 | Gardasil, Gardasil 9 |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Incyte Corporation | $23.13 | 2025 | Opzelura |
| Hologic Sales and Service, LLC | $19.06 | 2021 | |
| Dysis Medical, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.